Table 1 Patients demographics
Variables | Extracorporeal | Intracorporeal | P |
|---|---|---|---|
Patients, n | 19 | 19 | |
Age (mean ± SD), year | 62.5 ± 8.54 | 67.9 ± 11.40 | 0.173 |
BMI (mean ± SD), kg/m2 | 25.5 ± 2.97 | 25.3 ± 2.74 | 0.867 |
Charlson comorbidity index (median [range]) | 4 [2–9] | 3 [2–5] | 0.548 |
ASA score, n | > 0.9 | ||
1–2 | 17 (89%) | 17 (89%) | |
3 | 2 (11%) | 2 (11%) | |
Neoadjuvant chemotherapy, n (%) | 4 (21%) | 3 (16%) | > 0.9 |
Pre-eGFR (mean ± SD), mL/(min·1.73 m2) | 86.3 ± 28.87 | 85.9 ± 34.57 | 0.972 |
Pre-Hb (mean ± SD), g/L | 116.9 ± 16.81 | 118.6 ± 13.94 | 0.765 |
Preoperative diagnosis, n | > 0.9 | ||
NMIBC | 7 (37%) | 8 (42%) | |
MIBC | 12 (63%) | 11 (58%) | |
Clinical stage | 0.720 | ||
Ta/T1/Tis | 7 (37%) | 8 (42%) | |
T2 | 9 (47%) | 5 (26%) | |
T3 | 3 (16%) | 5 (26%) | |
T4 | 0 (0%) | 1 (5%) | |
Clinical stage | 0.405 | ||
N0 | 17 (89%) | 14 (74%) | |
N1 | 2 (11%) | 5 (26%) |